Lonza Group AG (SWX:LONN)
Switzerland · Delayed Price · Currency is CHF 592.20
+6.40 (1.09%)
Aug 21, 2026, 5:31 PM CET
Lonza Group AG Financials Overview
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 6,871 | 6,531 | 5,480 | 6,717 | 6,223 | 5,409 |
Revenue Growth | 5.21% | 19.18% | -18.42% | 7.94% | 15.05% | 19.99% |
Gross Profit Gross Profit Growth | 2,552 | 2,349 | 2,006 | 2,403 | 2,438 | 2,110 |
Operating Income Operating Income Growth | 1,614 | 1,397 | 1,110 | 1,365 | 1,387 | 846 |
Net Income Net Income Growth | -110 | -275 | 636 | 654 | 1,215 | 2,944 |
Earnings Per Share EPS Growth | -1.57 | -3.93 | 8.92 | 8.88 | 16.34 | 39.52 |
EPS Growth | - | - | 0.45% | -45.66% | -58.66% | 239.83% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Integrated Biologics Integrated Biologics Growth | 3,706 | 3,649 | 2,883 | 3,719 | 3,274 | 2,699 |
Advanced Synthesis Advanced Synthesis Growth | 1,768 | 1,611 | 1,323 | 901 | 819 | 767 |
Specialized Modalities Specialized Modalities Growth | 1,113 | 1,034 | 1,099 | 696 | 693 | 602 |
Corporate Corporate Growth | 265 | 237 | 175 | 240 | 171 | 137 |
Revenue (Total) Revenue (Total) Growth | 6,329 | 6,531 | 5,480 | 6,717 | 6,223 | 5,409 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 487 | 719 | 1,711 | 1,669 | 2,224 | 3,184 |
Total Debt Total Debt Growth | 4,167 | 4,679 | 5,228 | 3,160 | 2,587 | 2,749 |
Net Cash (Debt) Net Cash Growth | -3,680 | -3,960 | -3,517 | -1,491 | -363 | 435 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -52.66 | -56.55 | -49.33 | -20.24 | -4.88 | 5.84 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,435 | 1,156 | 1,274 | 1,388 | 1,020 | 1,217 |
Capital Expenditures CapEx Growth | -1,228 | -1,321 | -1,381 | -1,648 | -1,826 | -1,301 |
Free Cash Flow Free Cash Flow Growth | 207 | -165 | -107 | -260 | -806 | -84 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 37.14% | 35.97% | 36.61% | 35.77% | 39.18% | 39.01% |
Operating Margin | 23.49% | 21.39% | 20.26% | 20.32% | 22.29% | 15.64% |
Pretax Margin | 19.21% | 16.86% | 12.92% | 11.76% | 23.27% | 14.05% |
Profit Margin | -1.60% | -4.21% | 11.61% | 9.74% | 19.52% | 54.43% |
FCF Margin | 3.01% | -2.53% | -1.95% | -3.87% | -12.95% | -1.55% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 5.000 | 5.000 | 4.000 | 4.000 | 3.500 | 3.000 |
Dividend Per Share Growth | 25.00% | 25.00% | 0% | 14.29% | 16.67% | 0% |
Dividend Yield | 0.88% | 0.94% | 0.76% | 1.16% | 0.80% | 0.41% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 38.28 | - | 60.85 | 40.17 | 27.67 | 19.22 |
Forward PE | 29.25 | 28.27 | 34.02 | 28.59 | 27.11 | 50.68 |
PS Ratio | 6.02 | 5.78 | 7.06 | 3.91 | 5.40 | 10.46 |